Author | Joseph M. Flynn, DO | OncLive

Author | Joseph M. Flynn, DO

Articles

Dr. Flynn on Obinutuzumab for the Treatment of CLL

August 25, 2014

Video

Joseph M. Flynn, DO, MPH, discusses the results of the phase II GAGE study, which compared 1000 mg vs 2000 mg of obinutuzumab in patients with chronic lymphocytic leukemia (CLL).

Dr. Flynn Discusses Ibrutinib for Hematologic Malignancies

July 28, 2014

Video

Joseph M. Flynn, DO, MPH, co-director, Division of Hematology; co-director, LIVESTRONG Survivorship Center of Excellence; medical director, James Survivorship Clinics, The Ohio State University, James Cancer Hospital, discusses the impact ibrutinib has had on treating hematologic malignancies.

Dr. Flynn on CDK Inhibitors for the Treatment of CLL

April 07, 2014

Video

Joseph M. Flynn, DO, MPH, FACP, co-director, Division of Hematology, associate physician-in-chief, OSUCCC - James, discusses cyclin-dependent kinase (CDK) inhibitors for the treatment of chronic lymphocytic leukemia (CLL).

x